Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma

被引:52
作者
Mastropasqua, Leonardo [1 ]
Agnifili, Luca [1 ]
Mastropasqua, Rodolfo [2 ]
Fasanella, Vincenzo [1 ]
机构
[1] Univ G dAnnunzio, Ophthalm Clin, Dept Med & Ageing Sci, Chieti, Italy
[2] Univ Verona, Ophthalmol Unit, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy
关键词
OPEN-ANGLE GLAUCOMA; TOPICAL ANTIGLAUCOMA DRUGS; IN-VIVO ANALYSIS; BENZALKONIUM CHLORIDE; OCULAR SURFACE; INFLAMMATORY MARKERS; MITOMYCIN-C; CELLS; LATANOPROST; EXPRESSION;
D O I
10.1016/j.coph.2012.10.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lowering intra-ocular pressure, either medically or surgically, is the proven strategy to control glaucoma, though profound changes to the ocular surface and conjunctiva are caused. Toxicity and allergy initiated by medical therapy induce modifications, which progressively worsen with the length of treatment and number of drugs. Conjunctival changes lead to symptoms of ocular surface disease, reduced quality of life, reduced therapeutic compliance and increased risk of surgical failure. Surgery modifies conjunctiva by inducing bleb formation in fistulizing techniques, and by activating secondary aqueous humour outflow pathways, such as trans-scleral routes; in both filtration and bleb-less approaches. The use of unpreserved medications, limitation of intra-operative conjunctival damage and development of bleb-less surgery are advisable.
引用
收藏
页码:56 / 64
页数:9
相关论文
共 52 条
[1]  
Agnifili L, 2011, ACTA OPHTHALMOL
[2]   Histological findings of failed gold micro shunts in primary open-angle glaucoma [J].
Agnifili, Luca ;
Costagliola, Ciro ;
Figus, Michele ;
Iezzi, Giovanna ;
Piattelli, Adriano ;
Carpineto, Paolo ;
Mastropasqua, Rodolfo ;
Nardi, Marco ;
Mastropasqua, Leonardo .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (01) :143-149
[3]   Side Effects Associated with Prostaglandin Analog Therapy [J].
Alm, Albert ;
Grierson, Ian ;
Shields, M. Bruce .
SURVEY OF OPHTHALMOLOGY, 2008, 53 :S93-S105
[4]   Filtering blebs and aqueous pathway -: An immunocytological and in vivo confocal microscopy study [J].
Amar, Nawel ;
Labbe, Antoine ;
Hamard, Pascale ;
Dupas, Benedicte ;
Baudouin, Christophe .
OPHTHALMOLOGY, 2008, 115 (07) :1154-1161
[5]   Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells [J].
Ammar, David A. ;
Noecker, Robert J. ;
Kahook, Malik Y. .
ADVANCES IN THERAPY, 2010, 27 (11) :837-845
[6]   Effects of long-term topical anti-glaucoma medications on meibomian glands [J].
Arita, Reiko ;
Itoh, Kouzo ;
Maeda, Shuji ;
Maeda, Koshi ;
Furuta, Ayumu ;
Tomidokoro, Atsuo ;
Aihara, Makoto ;
Amano, Shiro .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 250 (08) :1181-1185
[7]   Second-generation Trabecular Meshwork Bypass Stent (iStent inject) Increases Outflow Facility in Cultured Human Anterior Segments [J].
Bahler, Cindy K. ;
Hann, Cheryl R. ;
Fjield, Todd ;
Haffner, David ;
Heitzmann, Hal ;
Fautsch, Michael P. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 153 (06) :1206-1213
[8]   Ocular surface inflammatory changes induced by topical antiglaucoma drugs -: Human and animal studies [J].
Baudouin, C ;
Pisella, PJ ;
Fillacier, K ;
Goldschild, M ;
Becquet, F ;
De Saint Jean, M ;
Béchetoille, A .
OPHTHALMOLOGY, 1999, 106 (03) :556-563
[9]  
BAUDOUIN C, 1994, OPHTHALMOLOGY, V101, P454
[10]   Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term [J].
Baudouin, C ;
Hamard, P ;
Liang, H ;
Creuzot-Garcher, C ;
Bensoussan, L ;
Brignole, F .
OPHTHALMOLOGY, 2004, 111 (12) :2186-2192